drugset
drugset / Trial / NCT05881707

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

NCT05881707 ↗

Phase 1 Completed 44 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare the pharmacokinetic and safety of CKD-828 20/1.25mg

Timeline

Start
2023-07-04
Primary completion
2023-09-02
Completion
2023-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-828 Unknown — Oral
Subject D064 Unknown — Oral
Subject D702 Unknown — Oral

Indications

hypertensive disorder